The promotion of bone regeneration through positive regulation ofangiogenic-osteogenic coupling using microRNA-26a

Biomaterials

Volumn 34, Issue 21, 2013, Pages 5048-5058

  Li, Yan ^a   Fan, Longkun ^a,b   Liu, Shiyu ^a   Liu, Wenjia ^a   Zhang, Hao ^a   Zhou, Tao ^a   Wu, Dan ^a   Yang, Ping ^a   Shen, Lijuan ^a   Chen, Jihua ^a   Jin, Yan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CANGZHOU CENTRAL HOSPITAL   (China)

Author keywords

Angiogenesis; Bone regeneration; Hydrogel; Osteogenesis; RNAi

Indexed keywords

ANGIOGENESIS; BONE DEVELOPMENT; BONE REGENERATION; DELIVERY SYSTEMS; ENDOGENOUS SIGNALING; OSTEOGENESIS; RNAI; VASCULARIZED TISSUES;

ASSAYS; HYDROGELS; POLYMERASE CHAIN REACTION; REPAIR; RNA; TISSUE;

BONE;

MICRORNA 26A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REGENERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKULL DEFECT; VASCULARIZATION; WESTERN BLOTTING;

ANIMALS; BONE AND BONES; BONE REGENERATION; CELL DIFFERENTIATION; ENHANCER ELEMENTS, GENETIC; GENE TRANSFER TECHNIQUES; HUMANS; HYDROGEL; MICE; MICE, INBRED C57BL; MICRORNAS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOGENESIS; WOUND HEALING;

EID: 84877029650     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.03.052     Document Type: Article

References (49)

1. Crane G.M., Ishaug S.L., Mikos A.G. Bone tissue engineering. Nat Med 1995, 1:1322-1324.
2. Rouwkema J., Rivron N.C., van Blitterswijk C.A. Vascularization in tissue engineering. Trends Biotechnol 2008, 26:434-441.
3. Gerber H.P., Ferrara N. Angiogenesis and bone growth. Trends Cardiovasc Med 2000, 10:223-228.
4. Collin-Osdoby P. Role of vascular endothelial cells in bone biology. JCell Biochem 1994, 55:304-309.
5. Baron J., Klein K.O., Yanovski J.A., Novosad J.A., Bacher J.D., Bolander M.E., et al. Induction of growth plate cartilage ossification by basic fibroblast growth factor. Endocrinology 1994, 135:2790-2793.
6. Ivkovic S., Yoon B.S., Popoff S.N., Safadi F.F., Libuda D.E., Stephenson R.C., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003, 130:2779-2791.
7. Kanczler J.M., Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
8. Schipani E., Maes C., Carmeliet G., Semenza G.L. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. JBone Miner Res 2009, 24:1347-1353.
9. Lin L., Shen Q., Leng H., Duan X., Fu X., Yu C. Synergistic inhibition of endochondral bone formation by silencing Hif1alpha and Runx2 in trauma-induced heterotopic ossification. Mol Ther 2011, 19:1426-1432.
10. Peng H., Wright V., Usas A., Gearhart B., Shen H.C., Cummins J., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. JClin Invest 2002, 110:751-759.
11. Wadhwa S., Bi Y., Ortiz A.T., Embree M.C., Kilts T., Iozzo R., et al. Impaired posterior frontal sutural fusion in the biglycan/decorin double deficient mice. Bone 2007, 40:861-866.
12. Wildemann B., Kandziora F., Krummrey G., Palasdies N., Haas N.P., Raschke M., et al. Local and controlled release of growth factors (combination of IGF-I and TGF-beta I, and BMP-2 alone) from a polylactide coating of titanium implants does not lead to ectopic bone formation in sheep muscle. JControl Release 2004, 95:249-256.
13. Zhang Y., Shi B., Li C., Wang Y., Chen Y., Zhang W., et al. The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chitosan/collagen scaffolds. JControl Release 2009, 136:172-178.
14. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Rueger D.C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res 1994, 302-312.
15. Cook S.D., Wolfe M.W., Salkeld S.L., Rueger D.C. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. JBone Joint Surg Am 1995, 77:734-750.
16. Andreadis S.T., Geer D.J. Biomimetic approaches to protein and gene delivery for tissue regeneration. Trends Biotechnol 2006, 24:331-337.
17. Chen F.M., Zhang M., Wu Z.F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010, 31:6279-6308.
18. Yau W.W., Rujitanaroj P.O., Lam L., Chew S.Y. Directing stem cell fate by controlled RNA interference. Biomaterials 2012, 33:2608-2628.
19. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
20. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
21. Li H., Xie H., Liu W., Hu R., Huang B., Tan Y.F., et al. Anovel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. JClin Invest 2009, 119:3666-3677.
22. Zhang J.F., Fu W.M., He M.L., Xie W.D., Lv Q., Wan G., et al. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol 2011, 8:829-838.
23. Yang N., Wang G., Hu C., Shi Y., Liao L., Shi S., et al. TNF-alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. JBone Miner Res 2012.
24. Li Z., Hassan M.Q., Jafferji M., Aqeilan R.I., Garzon R., Croce C.M., et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. JBiol Chem 2009, 284:15676-15684.
25. Eskildsen T., Taipaleenmaki H., Stenvang J., Abdallah B.M., Ditzel N., Nossent A.Y., et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells invivo. Proc Natl Acad Sci U S A 2011, 108:6139-6144.
26. Luzi E., Marini F., Sala S.C., Tognarini I., Galli G., Brandi M.L. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. JBone Miner Res 2008, 23:287-295.
27. Huse J.T., Brennan C., Hambardzumyan D., Wee B., Pena J., Rouhanifard S.H., et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis invivo. Genes Dev 2009, 23:1327-1337.
28. Su J.D., Mayo L.D., Donner D.B., Durden D.L. PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment. Cancer Res 2003, 63:3585-3592.
29. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010, 12:247-256.
30. Liu L.Z., Li C., Chen Q., Jing Y., Carpenter R., Jiang Y., et al. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS One 2011, 6:e19139.
31. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., et al. Silencing of microRNAs invivo with 'antagomirs'. Nature 2005, 438:685-689.
32. Matsubara T., Suardita K., Ishii M., Sugiyama M., Igarashi A., Oda R., et al. Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. JBone Miner Res 2005, 20:399-409.
33. Zhou J., Lin H., Fang T., Li X., Dai W., Uemura T., et al. The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone. Biomaterials 2010, 31:1171-1179.
34. Boerckel J.D., Uhrig B.A., Willett N.J., Huebsch N., Guldberg R.E. Mechanical regulation of vascular growth and tissue regeneration invivo. Proc Natl Acad Sci U S A 2011, 108:E674-E680.
35. Yoshikawa T., Ihira M., Suzuki K., Suga S., Kito H., Iwasaki T., et al. Fatal acute myocarditis in an infant with human herpesvirus 6 infection. JClin Pathol 2001, 54:792-795.
36. Oskowitz A.Z., Lu J., Penfornis P., Ylostalo J., McBride J., Flemington E.K., et al. Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci U S A 2008, 105:18372-18377.
37. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. JClin Invest 2000, 106:829-838.
38. Tille J.C., Wood J., Mandriota S.J., Schnell C., Ferrari S., Mestan J., et al. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis invivo and invitro. JPharmacol Exp Ther 2001, 299:1073-1085.
39. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005, 97:512-523.
40. Lian J.B., Stein G.S., van Wijnen A.J., Stein J.L., Hassan M.Q., Gaur T., et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 2012, 8:212-227.
41. Wienholds E., Plasterk R.H. MicroRNA function in animal development. FEBS Lett 2005, 579:5911-5922.
42. Manaka T., Suzuki A., Takayama K., Imai Y., Nakamura H., Takaoka K. Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials 2011, 32:9642-9648.
43. Mariner P.D., Johannesen E., Anseth K.S. Manipulation of miRNA activity accelerates osteogenic differentiation of hMSCs in engineered 3D scaffolds. JTissue Eng Regen Med 2012, 6:314-324.
44. Lian J.B., Stein G.S., Javed A., van Wijnen A.J., Stein J.L., Montecino M., et al. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 2006, 7:1-16.
45. Cowles E.A., DeRome M.E., Pastizzo G., Brailey L.L., Gronowicz G.A. Mineralization and the expression of matrix proteins during invivo bone development. Calcif Tissue Int 1998, 62:74-82.
46. Cai S., Liu Y., Zheng Shu X., Prestwich G.D. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 2005, 26:6054-6067.
47. Oh Y.K., Park T.G. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 2009, 61:850-862.
48. Schumann P., Tavassol F., Lindhorst D., Stuehmer C., Bormann K.H., Kampmann A., et al. Consequences of seeded cell type on vascularization of tissue engineering constructs invivo. Microvasc Res 2009, 78:180-190.
49. Al-Khaldi A., Eliopoulos N., Martineau D., Lejeune L., Lachapelle K., Galipeau J. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response invivo. Gene Ther 2003, 10:621-629.